HEADER OXIDOREDUCTASE 09-JUN-06 2H9I TITLE MYCOBACTERIUM TUBERCULOSIS INHA BOUND WITH ETH-NAD ADDUCT COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH]; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: NADH- DEPENDENT ENOYL-ACP REDUCTASE; COMPND 5 EC: 1.3.1.9; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 1773; SOURCE 4 GENE: INHA; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS INHA, ETHIONAMIDE, ETH, TUBERCULOSIS, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR F.WANG,J.C.SACCHETTINI REVDAT 6 30-AUG-23 2H9I 1 REMARK REVDAT 5 20-OCT-21 2H9I 1 REMARK SEQADV REVDAT 4 13-JUL-11 2H9I 1 VERSN REVDAT 3 24-FEB-09 2H9I 1 VERSN REVDAT 2 06-FEB-07 2H9I 1 JRNL REVDAT 1 30-JAN-07 2H9I 0 JRNL AUTH F.WANG,R.LANGLEY,G.GULTEN,L.G.DOVER,G.S.BESRA,W.R.JACOBS, JRNL AUTH 2 J.C.SACCHETTINI JRNL TITL MECHANISM OF THIOAMIDE DRUG ACTION AGAINST TUBERCULOSIS AND JRNL TITL 2 LEPROSY. JRNL REF J.EXP.MED. V. 204 73 2007 JRNL REFN ISSN 0022-1007 JRNL PMID 17227913 JRNL DOI 10.1084/JEM.20062100 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.98 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 44255.090 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.0 REMARK 3 NUMBER OF REFLECTIONS : 19820 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.233 REMARK 3 FREE R VALUE : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1936 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 86.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2649 REMARK 3 BIN R VALUE (WORKING SET) : 0.3440 REMARK 3 BIN FREE R VALUE : 0.3480 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 296 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.020 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1993 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 34 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 9.87000 REMARK 3 B22 (A**2) : 9.87000 REMARK 3 B33 (A**2) : -19.74000 REMARK 3 B12 (A**2) : 17.17000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM SIGMAA (A) : 0.32 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.36 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.38 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.020 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.31 REMARK 3 BSOL : 30.61 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : EAD.PAR REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : EAD.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2H9I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-JUN-06. REMARK 100 THE DEPOSITION ID IS D_1000038098. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 121 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : ADSC REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20969 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1ENY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.05 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% MDP, 4% DMSO, 0.1M HEPES, 0.025M REMARK 280 SODIUM CITRATE, PH 7.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 62 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z REMARK 290 5555 Y,-X+Y,Z+2/3 REMARK 290 6555 X-Y,X,Z+1/3 REMARK 290 7555 Y,X,-Z+2/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+1/3 REMARK 290 10555 -Y,-X,-Z+2/3 REMARK 290 11555 -X+Y,Y,-Z REMARK 290 12555 X,X-Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 93.61333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 46.80667 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 93.61333 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 46.80667 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 93.61333 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 46.80667 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 93.61333 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 46.80667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A HEXAMER GENERATED FROM THE REMARK 300 MONOMER IN THE ASYMMETRIC UNIT REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 20190 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 33630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -102.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -48.96700 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 84.81333 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 -1.000000 46.80667 REMARK 350 BIOMT1 4 0.500000 0.866025 0.000000 -48.96700 REMARK 350 BIOMT2 4 0.866025 -0.500000 0.000000 84.81333 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 46.80667 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 16 -35.21 -133.00 REMARK 500 PHE A 41 -92.82 -69.62 REMARK 500 ARG A 43 67.19 -104.11 REMARK 500 ALA A 157 -55.24 70.60 REMARK 500 ASN A 159 -114.25 29.43 REMARK 500 SER A 247 -169.78 -76.94 REMARK 500 ALA A 260 73.10 -114.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EAD A 300 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ZID RELATED DB: PDB REMARK 900 LONG FATTY ACID CHAIN ENOYL-ACP REDUCTASE (INHA) IN COMPLEX WITH AN REMARK 900 ISONICOTINIC-ACYL-NADH INHIBITOR DBREF 2H9I A 3 269 UNP P0A5Y6 INHA_MYCTU 3 269 SEQADV 2H9I ALA A 2 UNP P0A5Y6 ENGINEERED MUTATION SEQRES 1 A 268 ALA GLY LEU LEU ASP GLY LYS ARG ILE LEU VAL SER GLY SEQRES 2 A 268 ILE ILE THR ASP SER SER ILE ALA PHE HIS ILE ALA ARG SEQRES 3 A 268 VAL ALA GLN GLU GLN GLY ALA GLN LEU VAL LEU THR GLY SEQRES 4 A 268 PHE ASP ARG LEU ARG LEU ILE GLN ARG ILE THR ASP ARG SEQRES 5 A 268 LEU PRO ALA LYS ALA PRO LEU LEU GLU LEU ASP VAL GLN SEQRES 6 A 268 ASN GLU GLU HIS LEU ALA SER LEU ALA GLY ARG VAL THR SEQRES 7 A 268 GLU ALA ILE GLY ALA GLY ASN LYS LEU ASP GLY VAL VAL SEQRES 8 A 268 HIS SER ILE GLY PHE MET PRO GLN THR GLY MET GLY ILE SEQRES 9 A 268 ASN PRO PHE PHE ASP ALA PRO TYR ALA ASP VAL SER LYS SEQRES 10 A 268 GLY ILE HIS ILE SER ALA TYR SER TYR ALA SER MET ALA SEQRES 11 A 268 LYS ALA LEU LEU PRO ILE MET ASN PRO GLY GLY SER ILE SEQRES 12 A 268 VAL GLY MET ASP PHE ASP PRO SER ARG ALA MET PRO ALA SEQRES 13 A 268 TYR ASN TRP MET THR VAL ALA LYS SER ALA LEU GLU SER SEQRES 14 A 268 VAL ASN ARG PHE VAL ALA ARG GLU ALA GLY LYS TYR GLY SEQRES 15 A 268 VAL ARG SER ASN LEU VAL ALA ALA GLY PRO ILE ARG THR SEQRES 16 A 268 LEU ALA MET SER ALA ILE VAL GLY GLY ALA LEU GLY GLU SEQRES 17 A 268 GLU ALA GLY ALA GLN ILE GLN LEU LEU GLU GLU GLY TRP SEQRES 18 A 268 ASP GLN ARG ALA PRO ILE GLY TRP ASN MET LYS ASP ALA SEQRES 19 A 268 THR PRO VAL ALA LYS THR VAL CYS ALA LEU LEU SER ASP SEQRES 20 A 268 TRP LEU PRO ALA THR THR GLY ASP ILE ILE TYR ALA ASP SEQRES 21 A 268 GLY GLY ALA HIS THR GLN LEU LEU HET EAD A 300 54 HETNAM EAD {(2R,3S,4R,5R)-5-[(4S)-3-(AMINOCARBONYL)-4-(2- HETNAM 2 EAD ETHYLISONICOTINOYL)PYRIDIN-1(4H)-YL]-3,4- HETNAM 3 EAD DIHYDROXYTETRAHYDROFURAN-2-YL}METHYL [(2R,3S,4R,5R)-5- HETNAM 4 EAD (6-AMINO-9H-PURIN-9-YL)-3,4-DIHYDROXYTETRAHYDROFURAN- HETNAM 5 EAD 2-YL]METHYL DIHYDROGEN DIPHOSPHATE HETSYN EAD 2-ETHYL-ISONICOTINIC-ACYL-NICOTINAMIDE-ADENINE HETSYN 2 EAD DINUCLEOTIDE FORMUL 2 EAD C29 H36 N8 O15 P2 FORMUL 3 HOH *34(H2 O) HELIX 1 1 SER A 20 GLN A 32 1 13 HELIX 2 2 ARG A 43 ASP A 52 1 10 HELIX 3 3 ASN A 67 GLY A 83 1 17 HELIX 4 4 PRO A 99 MET A 103 5 5 HELIX 5 5 PRO A 107 ALA A 111 5 5 HELIX 6 6 PRO A 112 ALA A 124 1 13 HELIX 7 7 ALA A 124 LEU A 135 1 12 HELIX 8 8 TYR A 158 GLY A 180 1 23 HELIX 9 9 LYS A 181 GLY A 183 5 3 HELIX 10 10 THR A 196 GLY A 204 1 9 HELIX 11 11 GLY A 208 ALA A 226 1 19 HELIX 12 12 ALA A 235 SER A 247 1 13 HELIX 13 13 GLY A 263 GLN A 267 5 5 SHEET 1 A 7 LEU A 60 GLU A 62 0 SHEET 2 A 7 GLN A 35 GLY A 40 1 N LEU A 38 O LEU A 61 SHEET 3 A 7 ARG A 9 VAL A 12 1 N ILE A 10 O GLN A 35 SHEET 4 A 7 LEU A 88 HIS A 93 1 O ASP A 89 N ARG A 9 SHEET 5 A 7 MET A 138 ASP A 148 1 O VAL A 145 N HIS A 93 SHEET 6 A 7 ARG A 185 ALA A 191 1 O ARG A 185 N ILE A 144 SHEET 7 A 7 ASP A 256 ALA A 260 1 O ILE A 258 N LEU A 188 SITE 1 AC1 31 GLY A 14 ILE A 15 ILE A 16 SER A 20 SITE 2 AC1 31 ILE A 21 PHE A 41 LEU A 63 ASP A 64 SITE 3 AC1 31 VAL A 65 SER A 94 ILE A 95 GLY A 96 SITE 4 AC1 31 ILE A 122 MET A 147 ASP A 148 PHE A 149 SITE 5 AC1 31 MET A 155 TYR A 158 LYS A 165 ALA A 191 SITE 6 AC1 31 GLY A 192 PRO A 193 ILE A 194 THR A 196 SITE 7 AC1 31 MET A 199 TRP A 222 HOH A 302 HOH A 315 SITE 8 AC1 31 HOH A 320 HOH A 325 HOH A 330 CRYST1 97.934 97.934 140.420 90.00 90.00 120.00 P 62 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010211 0.005895 0.000000 0.00000 SCALE2 0.000000 0.011791 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007121 0.00000